I
Immix Biopharma, Inc.
IMMX · NASDAQ · Healthcare · 597M
Price · close
$13.66
+3.80% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.8×
Enterprise value / EBITDAEV/EBITDA
-12.1×
Free cash flow yieldFCF yield
-5.5%
Return on equityROE
-31.4%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
3.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.